Tacrolimus ophthalmic suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tacrolimus ophthalmic suspension, covering 2014-09-01 to 2014-09-01. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis [Phase 3]